Perseus Mining【PRU】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
オーストラリア
ASX
Perseus Mining Limited (PRU) 銘柄情報

Perseus Mining Limited (PRU)

2.46

-0.04

(-1.60%)

終了 11月15日 2:00PM

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

2.46

買値

2.45

売値

2.47

出来高

6,138,866

2.45 日の範囲 2.52

1.56 52 週間の範囲 3.00

時価総額

前日終値

2.50

始値

2.52

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

4,700,807

発行済株式数

1,367,463,113

配当利回り

-

PER

10.38

1 株当たり利益 (EPS)

0.24

歳入

1.03B

純利益

324.28M

セクター

Gold Ores

業界

Gold Ores

ウェブサイト

www.perseusmining.com

本社

Perth, Western Australia, Aus

設立

-

Perseus Mining Limited is listed in the Gold Ores sector of the オーストラリア証券取引所 with ticker PRU. The last closing price for Perseus Mining was AUD2.50. Over the last year, Perseus Mining shares have traded in a share price range of AUD 1.56 to AUD 3.00.

Perseus Mining currently has 1,367,463,113 shares in issue. The market capitalisation of Perseus Mining is AUD3.42 billion. Perseus Mining has a price to earnings ratio (PE ratio) of 10.38.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.36	-12.7659574468	2.82	2.82	2.45	6120913	2.5732829	DE
4	-0.35	-12.4555160142	2.81	3	2.45	5158296	2.78291008	DE
12	-0.11	-4.28015564202	2.57	3	2.31	4700807	2.63816935	DE
26	0.14	6.03448275862	2.32	3	2.23	4413270	2.54396864	DE
52	0.74	43.023255814	1.72	3	1.56	4508181	2.24407848	DE
156	0.67	37.4301675978	1.79	3	1.34	4744300	1.96981136	DE
260	1.605	187.719298246	0.855	3	0.63	5862805	1.58919173	DE

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
LRLLabyrinth Resources Ltd	AUD 0.26 (983.33%)	303.01k
NMLNavarre Minerals Ltd	AUD 0.10 (400.00%)	501.28k
BUYOBounty Oil & Gas	AUD 0.002 (100.00%)	49.43k
AUHAustChina Holdings Limited	AUD 0.002 (100.00%)	137.5k
BLZOBlaze Minerals Ltd	AUD 0.002 (100.00%)	415k
SCPScalare Partners Holdings Ltd	AUD 0.24 (-91.14%)	234.06k
CMOOCosmo Metals Ltd	AUD 0.005 (-50.00%)	342.41k
PAROParadigm Biopharmaceuticals Limited	AUD 0.001 (-50.00%)	385k
FAUFirst AU Limited	AUD 0.001 (-50.00%)	101k
EDEEden Innovations Ltd	AUD 0.001 (-33.33%)	600k
OVTOvanti Ltd	AUD 0.028 (-12.50%)	124.6M
DOUDouugh Limited	AUD 0.013 (-23.53%)	70.42M
FFGFatfish Group Limited	AUD 0.015 (-16.67%)	69.97M
ST1Spirit Technology Solutions Ltd	AUD 0.057 (3.64%)	68.75M
SYASayona Mining Limited	AUD 0.035 (0.00%)	67.38M

myjog

It appears that GTSM is agin trying to manipulate the stock price.
The incompetent-at-worst, inept-at-best, no-performance, no-capability management of this company is supposed to publish the latest 10-Q today. However considering the state in which management brought this company in, it’s ir

SonicCitadel16

SonicCitadel16 4分前

Do you talk to ronn since you say you are a major shareholder I am not a bashed or pumper

drugmanrx

drugmanrx 4分前

This part is interesting.as iy pretains to current shareholders going forward.

n exchange for ten million shares of NFTM common stock, NFTM has agreed to
acquire 100% of Strong AI Invest Limited's share capital. The transaction is estimated to
be worth $8 million. The NF

Batman412

Batman412 4分前

What a chance to grab twos im jealous

BefallenKnight

BefallenKnight 4分前

Hey, I gotta respect that you’re at the very least trying to keep on topic about RONN but you’re just pumping a scam. Good luck with that little buddy

fwb

If you are a SHAREHOLDER of SOUN, IMO you are sitting on a WINNING STOCK....
Lets see what SOUN PPS will be in 2 to 3 years.....
JMO
Nothing is for sure except DEATH and TAXES

Atlanta1

Atlanta1 4分前

Doc328

Yes, this is a double count as Blackrock changed their name to Blackrock Financial

Brooge warrants cancelled

Brooge warrants cancelled 5分前

same to you my brother

Filterthenoise

Filterthenoise 5分前

FUD that retrace

luvwetscent

luvwetscent 5分前

I too have followed Ford for years...Terrible management.

Savannah-Marc

Savannah-Marc 5分前

...how do you know it's "dilution" and not part of agreements made with the several joint venture companies to bring the hydrogen hubs online...
Sounds like you have some homework to do.

12x

It seems the 2024 post-CTAD run-up is over, with the peak SP reaching $10.45—matching the pre-Rett P3 run-up in 2023 exactly, though still significantly below the 2022 pre-CTAD AD Phase 2b/3 TLR peak of $15.24.

The next significant SP catalyst is the MAA submission PR, which could arr

Uncle Monkey

Uncle Monkey 5分前

told you all... more disappointments to come

La Flaca

La Flaca 5分前

Well, I was very fortunate to buy NVDA and APL at around the same time. It's astonishing to see 2700% and 790% gains, respectively in one of my accounts. Buy and hold works - credit to the Oracle of Omaha for those words of wisdom. My kids are the beneficiaries of Buffett's wisdom. :)

PennyStockTrader2

PennyStockTrader2 5分前

Im shocked they got back to me so quickly.

The company must verify their profile once per year. The company's profile has now expired.

Unbelievable. I will try and contact Michael and get this sorted out and fixed. Nothings easy.

haha11

$TQQQ......DLY.........S..H.line brooked...

https://schrts.co/SvRCBvng

LakeshoreLeo1953

LakeshoreLeo1953 5分前

Down this road SO MANY times.

Could it possibly be increased Russell
exposure by Retail?
Now that AVXL has bounced will THAT interest dry up?

Certainly tough to make the case that
SMART money owns 30+% of Anavex.

navycmdr

navycmdr 5分前

Booooom ! - Fannie / Freddie getting mkt ATTENTION ! - https://investorshub.advfn.com/uimage/uploads/2022/12/1/brdduvsjvb4aspx.gif

https://x.com/MariaBartiromo/status/1857055343072653671

ralphey

ralphey 5分前

Huge market opening up ! This just hot off the presses ! Greenland, Vatican City and Moldavia about to approve Vazkepa.

Brooge warrants cancelled

Brooge warrants cancelled 5分前

Budots

$UNCY Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update
– OLC New Drug Application (NDA) Accepted by the FDA with a PDUFA Target Action Date of June 28, 2025–

– Commercial Planning in Progress for 2025 Launch –

– Late Breaker

Budots

$UNCY Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update
– OLC New Drug Application (NDA) Accepted by the FDA with a PDUFA Target Action Date of June 28, 2025–

– Commercial Planning in Progress for 2025 Launch –

– Late Breaker

Sabien Technology

National Healthcare Prop... (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約